FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2993115270> ?p ?o ?g. }

• W2993115270 abstract "Elevated levels of C-reactive protein (CRP) in systemic sclerosis (SSc) have been linked to early inflammatory stages of the disease. This study has been designed to investigate CRP levels longitudinally in a cohort of SSc patients and to correlate these findings with comorbidities and disease characteristics.In this retrospective study, patients with SSc treated at the outpatient clinic of the Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, were analyzed. Only patients with at least three consecutive visits and at least 1 year follow-up were included in this study. CRP serum levels were measured at every visit and categorized as positive if CRP concentrations were ≥ 5 mg/l. Subjects with elevated CRP levels at more than 80% of visits were defined as inflammatory SSc. The longitudinal CRP profiles were correlated with disease characteristics and comorbidities.A total of 1815 consecutive visits of 131 SSc patients were analyzed. Over the observed time span (7.6 (1.0-19.5) years), 18.3% (n = 24) of patients had continuously elevated CRP levels (inflammatory SSc), whereas in 29% (n = 38), CRP levels were always in the normal range. There was no association between disease duration and CRP levels at first visit. Inflammatory SSc was associated with male gender (p = 0.022), anti-Scl-70 antibodies (p = 0.009), diffuse cutaneous SSc (p = 0.036), pulmonary fibrosis (p < 0.001), rheumatoid arthritis (p = 0.007), and cardiac arrhythmia (p = 0.048). Moreover, patients with inflammatory SSc revealed higher modified Rodnan skin scores (p < 0.001); lower forced vital capacity (FVC) (p < 0.001), total lung capacity (p = 0.001), and diffusing capacity (p = 0.008); and faster decline of FVC per year (p = 0.007). Even treatment with cyclophosphamide (CYC) did not decrease CRP levels (p = 0.754).Inflammatory SSc is characterized by a more severe phenotype, high morbidity, and a large proportion of male patients. Even treatment with CYC does not alter CRP levels in this subpopulation with a high unmet medical need." @default.
• W2993115270 created "2019-12-13" @default.
• W2993115270 creator A5004962774 @default.
• W2993115270 creator A5006763905 @default.
• W2993115270 creator A5013492221 @default.
• W2993115270 creator A5031669703 @default.
• W2993115270 creator A5034970451 @default.
• W2993115270 creator A5038404580 @default.
• W2993115270 creator A5071371941 @default.
• W2993115270 creator A5076831479 @default.
• W2993115270 creator A5081372430 @default.
• W2993115270 creator A5082907436 @default.
• W2993115270 creator A5091015214 @default.
• W2993115270 date "2019-12-01" @default.
• W2993115270 modified "2023-10-18" @default.
• W2993115270 title "Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide" @default.
• W2993115270 cites W1504572945 @default.
• W2993115270 cites W1855316965 @default.
• W2993115270 cites W1912193795 @default.
• W2993115270 cites W2016812439 @default.
• W2993115270 cites W2041443103 @default.
• W2993115270 cites W2046798079 @default.
• W2993115270 cites W2049511380 @default.
• W2993115270 cites W2070399299 @default.
• W2993115270 cites W2091259355 @default.
• W2993115270 cites W2114857739 @default.
• W2993115270 cites W2125371559 @default.
• W2993115270 cites W2135092690 @default.
• W2993115270 cites W2137412705 @default.
• W2993115270 cites W2164096595 @default.
• W2993115270 cites W2164264453 @default.
• W2993115270 cites W2169645723 @default.
• W2993115270 cites W2171849700 @default.
• W2993115270 cites W2304078890 @default.
• W2993115270 cites W2347093301 @default.
• W2993115270 cites W2400095976 @default.
• W2993115270 cites W2408925540 @default.
• W2993115270 cites W2750520295 @default.
• W2993115270 cites W2773901243 @default.
• W2993115270 cites W2782208928 @default.
• W2993115270 cites W2805702349 @default.
• W2993115270 cites W2806476436 @default.
• W2993115270 cites W2894919341 @default.
• W2993115270 cites W2981624279 @default.
• W2993115270 cites W2981960577 @default.
• W2993115270 cites W4211134725 @default.
• W2993115270 doi "https://doi.org/10.1186/s13075-019-2057-x" @default.
• W2993115270 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6889646" @default.
• W2993115270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31791379" @default.
• W2993115270 hasPublicationYear "2019" @default.
• W2993115270 type Work @default.
• W2993115270 sameAs 2993115270 @default.
• W2993115270 citedByCount "13" @default.
• W2993115270 countsByYear W29931152702020 @default.
• W2993115270 countsByYear W29931152702021 @default.
• W2993115270 countsByYear W29931152702022 @default.
• W2993115270 countsByYear W29931152702023 @default.
• W2993115270 crossrefType "journal-article" @default.
• W2993115270 hasAuthorship W2993115270A5004962774 @default.
• W2993115270 hasAuthorship W2993115270A5006763905 @default.
• W2993115270 hasAuthorship W2993115270A5013492221 @default.
• W2993115270 hasAuthorship W2993115270A5031669703 @default.
• W2993115270 hasAuthorship W2993115270A5034970451 @default.
• W2993115270 hasAuthorship W2993115270A5038404580 @default.
• W2993115270 hasAuthorship W2993115270A5071371941 @default.
• W2993115270 hasAuthorship W2993115270A5076831479 @default.
• W2993115270 hasAuthorship W2993115270A5081372430 @default.
• W2993115270 hasAuthorship W2993115270A5082907436 @default.
• W2993115270 hasAuthorship W2993115270A5091015214 @default.
• W2993115270 hasBestOaLocation W29931152701 @default.
• W2993115270 hasConcept C126322002 @default.
• W2993115270 hasConcept C198451711 @default.
• W2993115270 hasConcept C2776821229 @default.
• W2993115270 hasConcept C2776914184 @default.
• W2993115270 hasConcept C2777575956 @default.
• W2993115270 hasConcept C2781195455 @default.
• W2993115270 hasConcept C3020110884 @default.
• W2993115270 hasConcept C71924100 @default.
• W2993115270 hasConcept C72563966 @default.
• W2993115270 hasConcept C90924648 @default.
• W2993115270 hasConceptScore W2993115270C126322002 @default.
• W2993115270 hasConceptScore W2993115270C198451711 @default.
• W2993115270 hasConceptScore W2993115270C2776821229 @default.
• W2993115270 hasConceptScore W2993115270C2776914184 @default.
• W2993115270 hasConceptScore W2993115270C2777575956 @default.
• W2993115270 hasConceptScore W2993115270C2781195455 @default.
• W2993115270 hasConceptScore W2993115270C3020110884 @default.
• W2993115270 hasConceptScore W2993115270C71924100 @default.
• W2993115270 hasConceptScore W2993115270C72563966 @default.
• W2993115270 hasConceptScore W2993115270C90924648 @default.
• W2993115270 hasIssue "1" @default.
• W2993115270 hasLocation W29931152701 @default.
• W2993115270 hasLocation W29931152702 @default.
• W2993115270 hasLocation W29931152703 @default.
• W2993115270 hasLocation W29931152704 @default.
• W2993115270 hasOpenAccess W2993115270 @default.
• W2993115270 hasPrimaryLocation W29931152701 @default.
• W2993115270 hasRelatedWork W2150503314 @default.
• W2993115270 hasRelatedWork W2384738060 @default.
• W2993115270 hasRelatedWork W2394871571 @default.

• next